Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Many stock analysts see Indianapolis-based Elevance’s recent struggles as an opportunity. Thirteen of 24 analysts tracked by The Wall Street Journal rate the health insurer as a buy.

The board of Elevance Health, Inc. (NYSE:ELV) has announced that it will be paying its dividend of $1.71 on the 25th of March, an increased payment from last year's comparable dividend.

Despite a 29% drop in Elevance Health's stock, I maintain a strong buy rating due to a DCF price target of $549.60, indicating 43% upside. ELV's shift towards managed care, with strong industry ...